Atara Biotherapeutics

ATRANasdaq United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$76.136 M

$8.45 +2.42%

Close of 7 Aug 2026

Revenue

$120.8M

#2459 by revenue

Earnings

$32.7M

#1727 by earnings

Shares outstanding

8,178,114

Latest filing cover page

P/E ratio

2.3

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances) — ranked by market cap

All 160 →

#115Cognition TherapeuticsCGTX$96.7M
#116Cardiff OncologyCRDF$77.2M
#117Atara BiotherapeuticsATRA$76.1M
#118LeonaBioLONA$72.1M
#119Champions OncologyCSBR$72.1M

Where these numbers come from

Share counts and financials for Atara Biotherapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.